Intellepedia | Page 287 of 310

Pfizer files for Patent on Known Substance

This post examines Pfizer’s patent application on a known substance and the Indian Patent Office’s refusal in light of Section 3d and the Novartis decision. It discusses whether unpublished patent applications can render a substance as “known” and critiques the merging of novelty and subject matter analysis.

Pfizer falls prey to Section 3(d)

This post analyses the Indian Patent Office’s rejection of Pfizer’s Tofacitinib patent under Section 3(d). The decision addresses issues of novelty, inventive step, and the requirement for evidence of enhanced efficacy in pharmaceutical patent applications.

Intellectual Property (IP) in India: A Decade of Progress Part 13

This post examines the progress of geographical indications in India, with a focus on key agricultural and food products that have secured GI status. It also outlines the legal measures taken to safeguard these products’ distinct reputations.

Working of Patents – A Workable Proposition?

This article critically examines the working of patents in India, focusing on statutory requirements, compulsory licensing, and judicial interpretations. It discusses both commercial and non-commercial working, highlighting the practical complexities faced by patentees under the Indian Patents Act.

NSRCEL’S IP For Start-ups at IIMB a Grand Success

NSRCEL at IIM Bangalore organised a well-received event on intellectual property for startups. The programme offered practical guidance and resources to help entrepreneurs manage and protect their IP assets.

Lee Pharma v. AstraZeneca- An unfinished Patent Story

This post examines the Lee Pharma v. AstraZeneca case on compulsory licensing under Indian patent law. The Controller’s decision sheds light on the standards for proving public need, affordable pricing, and working of patents in India.

Intellectual Property (IP) in India: A Decade of Progress Part 12

This post explores the evolution of intellectual property rights in India with a focus on handloom and handicraft products registered as geographical indications. It provides an objective review of the legal framework and cultural significance of these protected goods.

PIL, IPO and Statement of Working of Patents

This post explores the statutory requirements for the statement of working of patents in India, assessing the legal provisions and practical challenges faced by the patent office. It provides an analytical perspective on compliance, resource implications, and public interest concerns within the Indian patent framework.

Audi taken for a ride

The Delhi High Court has issued an interim injunction restraining Audi AG from using the TT mark for selected goods in India, supporting TT Industries’ trademark rights. The order underscores the strength of prior registration and the scope of protection for Indian trademark holders.

Is Statement of Working of Patents For Public Interest?

The post analyses whether the statement of working of patents in India truly advances public interest or remains a procedural formality. It argues that while mandatory, its enforcement does not substantially benefit the public or the innovation ecosystem.